Amorphous form of 5-bromopyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluorophenyl)-1h-1,2,3-triazol-1-yl]-1-thio-alpha-d-galactopyranoside
AssigneeGalecto Biotech AB
InventorsLise GRAVELLE, Peter TIMMINS, Anders PEDERSEN
Life of this patent
Estimating the term…
Abstract
A stabilized amorphous form of a compound of formula I as well as compositions for oral administration including the compound of formula I in a therapeutically effective amount. Also, methods for treatment of a disease or disorder in which therapeutically effective amount of a composition including a compound of formula I is administered to a subject in need thereof.
Claims26
1-27. (canceled)
An amorphous form of a compound of formula I
An amorphous solid dispersion composition comprising:
- a mixture of an amorphous compound of formula I:
- and a polymer for stabilizing the amorphous form of the compound of formula I, and optionally a pharmaceutically acceptable additive.
A drug layered composition comprising a) an inert solid core having an outer surface and b) a mixture of amorphous compound of formula I:
- a polymer for stabilizing the amorphous form of the compound of formula I and optionally a pharmaceutically acceptable additive;
- wherein the mixture is a layer on the outer surface of the inert solid core.
Dependencies are inferred from the claim text.